J.WiddowsonP
GLP-1 and GIP inhibitors are amazing medications at doing what they were developed for managing blood sugar in people with type 2 diabetes and weight loss in obesity, study co-author Kelly Allison, a professor of psychiatry and director of the Center for Weight and Eating Disorders at Penn, said in the news release
Finally, while the expanding research into additional indications is promising, patients should be aware that off-label use for conditions like sleep apnea or cognitive decline lacks the rigorous evidence supporting approved indications
All clinical decisions are made by independent licensed providers
Our review of all the reported cases consistently displayed a female predominance (male:female=1:2.98), and when excluding black populations, female predominance was even more pronounced (male:female=1:6.23)
Efforts to reduce lipid levels can even promote disease progression, as FAO may induce oxidative stress, exhausting antioxidant competences and promoting damage to cellular organelles and DNA
